Autopsy report · NCT03270202

Wearable Devices to Promote Physical Activity

“discontinuation of financial support”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 month before it started.
• Ran for about 1 year 1 month before it stopped.
• 175 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Norwegian University of Science and Technology

Sponsor type

University, hospital or other

Conditions

Cardiovascular Diseases

Interventions

PAI group; Usual care

Participants

175

Sites

1

Countries

Norway

Trials that died the same way

• Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON)
  “Discontinuation of funding” (76% match in meaning)
• Biomechanics Research in the Effects of Interactive Dynamic Balance Training on Postural and Gait Control in Older Adults
  “Limitaiotn of financial support” (72% match in meaning)
• Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer
  “Withdrawal of funding support” (71% match in meaning)
• Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer
  “No financial support aproved” (67% match in meaning)
• Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids
  “Sponsor terminated financial support” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.